Among well-functioning older adults without
dementia, diabetes mellitus (DM) and poor glucose control among those with DM
are associated with worse cognitive function and greater cognitive decline,
according to a report published Online First by Archives of Neurology, a JAMA
Network publication.
Findings
from previous studies have suggested an association between diabetes mellitus
and an increased risk of cognitive impairment and dementia, including Alzheimer
disease, but this association continues to be debated and less is known
regarding incident DM in late life and cognitive function over time, the
authors write as background in the study.
Kristine
Yaffe, M.D., of the University of California, San Francisco and the San
Francisco VA Medical Center, and colleagues evaluated 3,069 patients (mean age,
74.2 years; 42 percent black; 52 percent female) who completed the Modified
Mini-Mental State Examination (3MS) and Digit Symbol Substitution Test (DSST)
at baseline and selected intervals over 10 years.
At
study baseline, 717 patients (23.4 percent) had prevalent DM and 2,352 (76.6
percent) were without DM, 159 of whom developed DM during follow-up. Patients
who had prevalent DM at baseline had lower 3MS and DSST test scores than
patients without DM, and results from analysis show similar patterns for 9-year
decline with participants with prevalent DM showing significant decline on both
the 3MS and DSST compared with those without DM.
Also,
among participants with prevalent DM at baseline, higher levels of hemoglobin A1c (HbA1c)
were associated with lower 3MS and DSST scores. However, after adjusting for
age, sex, race and education, scores remained significantly lower for those
with mid (7 percent to 8 percent) and high (greater than or equal to 8 percent)
HbA1c levels on the 3MS but were no longer significant for the DSST.
"This
study supports the hypothesis that older adults with
DM have reduced cognitive function and that poor glycemic control may
contribute to this association," the authors conclude. "Future
studies should determine if early diagnosis and treatment of DM lessen the risk
of developing cognitive impairment and if maintaining optimal glucose control helps
mitigate the effect of DM on cognition."
More
information: Arch
Neurol. Published online June 18, 2012.doi:10.1001/archneurol.2012.1117
Provided
by JAMA and
Archives Journals
No comments:
Post a Comment